FDA approves 1st-of-its-kind Parkinson’s drug
The FDA has approved AbbVie’s Juvmo (tavapadon) tablets for adults with Parkinson’s disease, making it the first and only selective D1/D5 receptor agonist approved for adults with the condition. The once-daily treatment can be taken with or without oral levodopa therapy, according to a Sept. 28 news release. AbbVie expects to make Juvmo available to […] The post FDA approves 1st-of-its-kind Parkinson’s drug appeared first on Becker's Hospital Review | Healthcare News...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.